Fig. 3From: Persistent luminescence nanoparticles for cancer theranostics application(Reproduced with permission [78]. Copyright 2018, Nature Publishing Group)a In vivo biodistribution of PEGylated PLNPs at different time points. b Ex vivo distribution of PEGylated PLNPs in vital organs at different time points. c PersL intensities of PEGylated PLNPs collected from isolated organs at different time points.Back to article page